Hackenberg S, Hacki T, Hagen R, Kleinsasser Norbert H
Universität Würzburg, Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, Plastische und Asthetische Operationen, Würzburg.
Laryngorhinootologie. 2010 Aug;89(8):460-4. doi: 10.1055/s-0030-1249694. Epub 2010 Aug 16.
Aasthma is one of the most common chronic diseases with a prevalence of 5% in Germany. Nearly half of the patients complain about permanent voice disorders. Mucosal changes due to the obstructive respiratory disease as well as mucus abnormalities and regularly accompanying chronic rhinosinusitis may explain these symptoms. The additional influence of laryngopharyngeal reflux is discussed controversially. Additionally, dysphonia may as well occur due to side effects of the therapy with inhaled corticosteroids: the ingredients as well as physical effects may be responsible for the development of chronic laryngitis. The concomitant therapy by an ENT specialist is important in asthma-related voice disorders to identify the basic cause of dysphonia systematically and to intervene at an early stage.
哮喘是最常见的慢性疾病之一，在德国的患病率为5%。近一半的患者抱怨有永久性嗓音障碍。阻塞性呼吸道疾病引起的黏膜变化以及黏液异常和经常伴发的慢性鼻-鼻窦炎可能解释了这些症状。关于喉咽反流的额外影响存在争议。此外，吸入性糖皮质激素治疗的副作用也可能导致发声困难：其成分以及物理作用可能是慢性喉炎发生的原因。对于与哮喘相关的嗓音障碍，耳鼻喉科专家的联合治疗很重要，以便系统地确定发声困难的根本原因并尽早进行干预。
